The latest thoracic oncology news
New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers…
Researchers at Wake Forest School of Medicine, USA, have discovered that nicotine promotes the spread…
Size and number of fused cancer and immune cells linked to survival in non-small cell…
The international study “Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific…
The international First-line Radiosurgery for Small-Cell Lung Cancer (FIRE-SCLC) analysis led by University of Colorado…
While nicotine is not actually carcinogenic, it is considered to be largely responsible for the…
Lung cancers account for approximately 25 percent of all cancer deaths. Even among those who…
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping…
Treatment with targeted therapy osimertinib following surgery for localised non-small cell lung cancer (NSCLC) with…
Lung cancer patients are at heightened risk for COVID-19 and the reported high mortality rate…